Clinical Trial

Project Mountain - Comparing SpO2 and SaO2 for Accuracy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 2, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The main goal of this study is to look at the performance of the neonatal, infant, and pediatric Philips SpO2 sensors with the Philips FAST Pulse Oximetry technology. Oxygen saturation measurements (SpO2) will be obtained via pulse oximetry and invasive arterial oxygen measurements (SaO2) will be obtained via arterial blood samples as part of your clinical care and assessed by co-oximetry. The study will aim to enroll a diverse population to help us understand the impact of skin pigmentation.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-04-16; most recent amendment 2025-04-01.
Status change: Not Yet Recruiting → Recruiting 2024-07-01
Trial Details
NCT Number NCT06372106
Lead Sponsor Philips Clinical & Medical Affairs Global
Conditions SpO2, Nasal Alar Collapse, Bilateral, Oxygen, Measurement
Enrollment 560 participants
Start Date 2024-04-04
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-04-02